Open AccessCirculating Vascular Endothelial Growth Factor and Soluble fms-Like Tyrosine Kinase-1 as Biomarkers for Endometrial Remodeling Across the Menstrual Cycle
Author(s) -
Jessica R. Zolton,
Lindsey A. Sjaarda,
Sunni Mumford,
Elizabeth A. DeVilbiss,
Keewan Kim,
Kerry S. Flannagan,
Jeannie G. Radoc,
Neil J. Perkins,
Robert M. Silver,
Jean WactawskiWende,
Micah J. Hill,
Alan H. DeCherney,
Enrique F. Schisterman
Publication year - 2020
Publication title -
obstetrics and gynecology (new york. 1953. online)/obstetrics and gynecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.664
H-Index - 220
eISSN - 1873-233X
pISSN - 0029-7844
DOI - 10.1097/aog.0000000000004171
Subject(s) - soluble fms like tyrosine kinase 1 , medicine , menstrual cycle , vascular endothelial growth factor , endocrinology , hormone , estrogen , placental growth factor , vegf receptors
To characterize variation in circulating vascular endothelial growth factor (VEGF) and its receptor, soluble fms-like tyrosine kinase-1 (sFLT-1), across the menstrual cycle in normal ovulating women in relation to reproductive hormones to identify the utility of VEGF and sFLT-1 as peripheral biomarkers of endometrial remodeling.